http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2171116-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86de7d9f2e6454d7c2f6aeaf3b9541b6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 1999-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb05db3345482715f6c1ebd11f35d30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ec47872a813f8197e357da4ce4fb98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11ae1854acee05c3821408d36cf0fa19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f27ff982acb398c62ba142b866aa7f
publicationDate 2001-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2171116-C2
titleOfInvention Neurotropic medicinal agent
abstract FIELD: medicine. SUBSTANCE: invention proposes the potentiated form of brain-specific protein S-100 taken in hundredth dilution C1-C10000. Agent shows the broad spectrum of action (sedative, tranquilizing, nootropic, psychoactive, antipsychotic, antiabstinent in alcoholism and narcomania). Agent can be used for correction of damaged immune homeostasis accompanying with alteration of psychosomatic functions and/or biological responses based on multiple effect on integrative activity of brain. EFFECT: enhanced effectiveness of agent, valuable medicinal properties, absence of adverse symptoms. 2 cl, 7 ex
priorityDate 1999-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491494

Total number of triples: 16.